Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

The IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling ...

The biotech industry in 2024 was marked by some contradictions: Even as layoffs continued to rip through companies large and ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi ...

Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, ...

The Indian IPO market has been bustling this year ... It competes with the likes of Syngene International, Divi's Laboratories and newly-listed Sai Life Sciences among Indian API makers. ($1 = 85.5720 ...

The successful debuts are expected to boost the IPO market, with eight new issuances ... retailer Vishal Mega Mart and pharma firm Sai Life Sciences gained around 40 per cent each.

Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent 18-Dec-2024 / 17:46 CET/CEST Release of an ad hoc ...

Sai Life Sciences IPO: The listing date of Sai Life Sciences Limited's initial public offering (IPO) has been fixed at 18 December 2024. According to the notice of the Indian exchanges ...